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ABSTRACT
OBJECTIVES: To investigate some epidemiological data of lichen
sclerosus patients; to verify its association with other conditions
and compare these data with the literature. METHODS:
Retrospective analysis of medical records of patients submitted to
12,724 vaginal/cervical examinations and vulvoscopies, at Hospital
do Servidor Público Estadual “Francisco Morato de Oliveira” – São
Paulo, from August 1998 to August 2001. RESULTS: The frequency
of lichen sclerosus confirmed by pathological examination was
0.73% among these patients. Mean age was 63.6 years. Most
patients presenting the condition were aged over 50 years (81/
93), and the difference was statistically significant as compared
with younger subjects (12/93). Caucasian women represented
91.4% of the sample and black, 8.6%. Smokers accounted for 8.6%
of the cases. Autoimmune diseases were detected in 31.2%,
psychiatric disorders in 17.2%, and neoplasms in 11.8% of those
suffering from lichen sclerosus. The colpocytology of one patient
was classified as Papanicolaou class V. CONCLUSION: These data
show the population studied presented findings similar to those
reported in the literature.
Keywords: Lichen sclerosus et atrophicus/epidemiology; Vulvar
diseases/pathology.
RESUMO
OBJETIVOS: Pesquisar alguns dados epidemiológicos referentes a
pacientes portadoras de líquen escleroso; verificar sua associação
com outras patologias e cotejar os dados com os da literatura.
MÉTODOS: Análise retrospectiva dos prontuários de pacientes que
se submeteram a 12.724 cervicovaginovulvoscopias, no Hospital
do Servidor Público Estadual “Francisco Morato de Oliveira” – São
Paulo, entre agosto de 1998 e agosto de 2001. RESULTADOS: A
freqüência do líquen escleroso, confirmado por exame anatomo-
patológico, foi de 0,73% entre as pacientes estudadas. A idade média
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foi de 63,6 anos. Entre as portadoras, a maioria tinha 50 anos ou
mais (81/93), diferença estatisticamente significativa em relação às
com menos idade (12/93). Eram brancas 91,4% e negras, 8,6%. As
tabagistas representaram 8,6% dos casos. Doenças auto-imunes
foram detectadas em 31,2% das portadoras do líquen escleroso,
doenças psiquiátricas em 17,2% e neoplasias em 11,8%. Uma
paciente teve sua colpocitologia oncótica classificada como classe
V de Papanicolaou. CONCLUSÃO: Os dados pesquisados mostraram
que a população estudada tem um comportamento concordante com
os dados da literatura.
Descritores: Líquen escleroso e atrófico/epidemiologia; Doenças da
vulva/patologia
INTRODUCTION
Lichen sclerosus (LE) corresponds to approximately 60% of the
cases of non-neoplastic epithelial disorder of the vulva, of
unknown etiology, according to the classification proposed by
the International Society of Gynecological Pathologists, in 1987(1-
2). It may be considered a skin disease, characterized by localized
areas of atrophy and discoloration of skin(1). LE is much more
frequent in women than in men (ratio of 10:1) and Caucasian
predominance is reported(3). Vulvar LE is a chronic disease and
its onset is usually in postmenopause, but it may occur at any
age, even in childhood(4). A characteristic monoclonal gamma-T-
cell receptor rearrangement was observed in this condition,
suggesting presence of a lichen sclerosus-associated antigen(5).
The process is asymptomatic in 15% of the cases(1); in the
remaining, pruritus is the most frequent symptom, leading to
vigorous itching with subsequent ulceration and ecchymosis,
which may impair diagnosis(3). The etiology is unknown and there
are hypotheses of hormonal and genetic alterations, and
autoimmune process(3,6). According to recent studies, the20 Linhares JJ, Zalc JM, Val RLR, Fonseca ESB, Lopes RGC, Lippi UG
PSYCHIATRIC DISEASES
PSIQUIÁTRICAS
NEOPLASM
ONCOLÓGICAS
AUTOIMMUNE DISEASES
AUTO-IMUNES
Figure 1. Distribution of associated diseases in lichen sclerosus
patients
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suggested infectious etiology was practically excluded(7). The
classic macroscopic image is a morphological alteration of the
vulva, with dry skin, loss of hair and disappearing of subcutaneous
fat(1). Fused labia minora over the urethra and important
involvement of the clitoris may occur(3). Deformity of vulvar
structures is characteristic of the most advanced phases of LE.
In order of frequency, the most affected structures are clitoris,
labia minora, vaginal orifice and labia majora, which present
diverse grades of involution, from mild hypotrophy to total
effacement. Vaginal orifice stenosis with dyspaurenia is the major
complication of the disease(8). The histopathological findings of
LE include a broad zone of hyalinization and papillar and
reticular dermis edema. Epidermal ridges may be absent and
epidermis becomes flat and hyperkeratotic. Atrophy may extend
beyond the dermis and affect subcutaneous tissue(9). In the
hyperkeratotic area, collagen fibers are swollen and homoge-
neous and contain only few nuclei. There is a significant change
in distribution of collagen I and III, apart from reduction in elastic
fibers(10). Blood and lymphatic vessels are dilated, and there might
be hemorhagic areas(5,11). Several autoimmune diseases are
associated with LE(2,7,9,12,13).
OBJECTIVES
To carry out a retrospective study of epidemiological data of LE
patients and verify frequency and types of associated conditions.
METHODS
The medical records of patients submitted to 12,724 vaginal/
cervical examinations and vulvoscopies, in the Division of Lower
Genital Tract Disease, Colposcopy and Prevention of Gynecologi-
cal Cancer of Hospital do Servidor Público Estadual “Francisco
Morato de Oliveira”, from August 1998 to August 2001, were
analyzed. Among the cases submitted to vulvoscopy followed by
biopsy, the prevalence of LE was confirmed by histopathological
examination. Its epidemiology and association with autoimmune
and psychiatric diseases and neoplams was evaluated. The
statistical analysis was performed by chi-square test, using Epi-
Info 5.01 (CDC).
RESULTS
In 12,724 vulvoscopies performed, 93 patients (0.73%) suffered
from LE. The mean age was 63.6 (+ 11.7) years, ranging from 32
to 93 years. There was a significant difference between the number
of patients with the condition aged under (12/93) and over (81/
93) 50 years (p < 0.00001).
Caucasian patients represented 91.4% (85/93), and black
patients, 8.6% (8/93). Smokers accounted for 8.6% (8/93).
Forty-nine (52.7%) out of 93 patients had one or more
associated diseases (fig 1). Autoimmune diseases (diabetes
mellitus type I, rheumatoid arthritis and systemic lupus
erythematous were the conditions most often observed) were
detected in 29 patients (31.2%); 16 patients (17.2%) suffered
from psychiatric disorders (mainly anxiety and depression); and
11 individuals (11.8%) had neoplastic diseases (ovary, uterine
cervix and gastrointestinal tract were the most common). The
associations observed among these patients were as follows: three
women presented psychiatric disorders and neoplams, three had
neoplasms and autoimmune diseases, and two suffered from
conditions related to the three groups. There was statistically
significant difference between the group of LE patients and the
group not presenting this condition for frequency of these
complications (chi-square = 11.5; p = 0.03). Pap smears showed
12.9% (12/93) of the patients in class I, 86.0% (80/93) in class II
and 1.1% (1/93) in class V.
DISCUSSION
According to the literature, the incidence of LE in the general
population is very low, as observed in this study. Regarding age
groups, the reports show higher incidence in subjects aged over 60
years and in postmenopausal period, although it may occur at any
age, even in prepubertal girls and in postpubertal period(4). The
sample assessed in this study was older.
As to race, the population evaluated presented findings
similar to those in the literature. There was a predominance of
Caucasian patients. The other factor assessed was smoking habit,
and most subjects were non-smokers. Although this aspect is
relevant, there are not enough data to justify it; on the other
hand, smoking is not a factor valued in the literature as associated
with this disease.
The etiology of LE is unknown, and there are hypotheses
of hormonal and genetic alterations, autoimmune processes and
excessive activation of elastase, which would digest the normal
elastic fibers(3). Results of a study of 30 vulvar LE cases
demonstrated significantly reduced serum dihydrotestosterone,
free testosterone and androstenedione levels, and it was
concluded there would be a decrease in 5a reductase levels(5).
The possible influence of genetic factors is demonstrated in
occasional reports of LE patient relatives, although familial
occurrence of the disease is rare(2). There are clinical and
histological descriptions of association with lichen planus and
localized scleroderma(7). Autoimmune phenomena are observed
in LE patients and their relatives: antithyroid antibodies and
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antigastric parietal cells, vitiligo, pernicious anemia, atrophic
gastritis, Sjögren’s syndrome, rheumatoid arthritis, systemic
lupus erythematous and scleroderma (the disease most often
associated with LE); however, more accurate studies are
necessary to explain these associations(8,14). A possible enzymatic
mechanism, related to increased activity of enzymes, such as
elastase, collagenase or amidase, in the fibroblasts of the skin
involved, could explain destruction of elastic dermal fibers(9).
In this casuistry, apart from association with autoimmune
diseases, a significant correlation between LE and psychiatric
diseases, or even with neoplasms, was found. Nevertheless,
despite the statistically significant difference when comparing
with the non-LE population, it is very difficult to establish if
there is a causal relation between the conditions or if the
association is related to older age groups. The literature
provides data on lichen sclerosus associated with HPV-negative
vulvar squamous cell carcinoma ranging from 7 to 96%(15).
These findings may trigger some prospective studies, evaluating
psychiatric diseases and their subtypes, as well as neoplasms, in
order to select the conditions that are more often associated with
LE and to determine screening procedures in this specific
population.
CONCLUSIONS
The results of the present study confirm the literature data
and raise questions about association of LE with autoimmune
and psychiatric diseases and neoplasms. This should be
prospectively evaluated in order to confirm the association
with LE; hence, a specific screening in this specific population
may be addressed.
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